+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theranostics Market - Global Forecast 2026-2032- Product Image
Theranostics Market - Global Forecast 2026-2032- Product Image
New

Theranostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083045
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The theranostics market is transforming precision medicine by uniting diagnostics and targeted therapies to achieve measurable advancements in patient outcomes and healthcare efficiency. As organizations seek actionable approaches to navigate complex innovation, theranostics is setting a new benchmark for integrated care and driving strategic conversations among healthcare leaders.

Market Snapshot: Theranostics Market Growth and Outlook

The global theranostics market grew from USD 3.32 billion in 2025 to USD 3.77 billion in 2026 and is on track to expand at a CAGR of 14.16%, reaching USD 8.40 billion by 2032. This robust growth underscores the increasing importance of multi-modal healthcare solutions, as leading technology firms, biopharmaceutical organizations, and healthcare providers position themselves to capitalize on new opportunities within integrated diagnostics and therapy systems.

Scope & Segmentation: Comprehensive Market Coverage

  • Product Types: Diagnostic agents support early disease detection, while therapeutic agents enable precise targeted treatment; both categories demand specialized development and regulatory strategies to ensure clinical efficacy and safety.
  • Technology Platforms: Advanced tools such as biomarker-based profiling, companion diagnostics, gene therapy modalities, molecular imaging systems, nanotechnology-driven drug delivery, radiopharmaceuticals, and targeted therapy solutions play pivotal roles in evolving clinical workflows.
  • Application Areas: The main uses extend across oncology—addressing cancers like breast, lung, prostate, thyroid, and neuroendocrine—as well as autoimmune, cardiovascular, neurological, metabolic, infectious, and inflammatory diseases, supporting applications that improve patient management and therapeutic response.
  • End-User Groups: Key stakeholders include diagnostic imaging centers, hospitals, cancer care facilities, specialty clinics, and research or academic institutes, each contributing to adoption trends, service delivery, and reimbursement mechanisms in the ecosystem.
  • Regional Coverage: Major regions include the Americas, known for sophisticated regulatory and clinical infrastructure; Europe, Middle East, and Africa, distinguished by diverse health policies and evolving access plans; and Asia-Pacific, where competitive adoption is propelled by government initiatives and expanding local expertise.

Key Takeaways: Strategic Insights for Decision-Makers

  • Theranostics dissolves barriers between diagnostics and therapy, presenting a model for personalized treatment that improves care precision and patient safety across clinical pathways.
  • Ongoing innovation in imaging technologies, molecular diagnostics, and nanotechnology is fueling a shift from standardized protocols to customized, patient-specific approaches.
  • Interdisciplinary collaboration among pharmaceutical, biotech, and device manufacturers accelerates development, drives new partnerships, and shapes evolving clinical pipelines for next-generation solutions.
  • Increasing regulatory acceptance of adaptive trial designs and real-world evidence helps reduce time to market and bolsters confidence in emerging theranostic products.
  • Expanding applications into multisystem disease areas are enhancing scalability, allowing stakeholders to address broader healthcare needs with integrated, data-driven solutions.

Tariff Impact on Supply Chains and Costs

Recent changes in United States tariffs have introduced additional cost pressures related to imports of radiopharmaceutical materials, nanotechnology components, and medical imaging devices. Manufacturers actively address these risks by shifting to domestic sourcing, forming closer partnerships with regional suppliers, and refining production strategies, while healthcare organizations assess the financial implications of adopting advanced theranostic technologies in a changing cost landscape.

Methodology & Data Sources

Analysis leverages structured interviews with key stakeholders, thorough reviews of scientific and industry literature, regulatory and patent datasets, and insights from primary industry publications. Comprehensive data triangulation and third-party expert validation ensure reliability in segmentation, along with practical recommendations.

Why This Report Matters

  • Supports senior executives in making informed investment decisions by mapping evolving technological innovations, commercial models, and changing policy frameworks in the theranostics market.
  • Delivers actionable competitive intelligence, identifies new clinical applications, and highlights cost management strategies vital for long-term growth in precision medicine.
  • Equips strategic planners with insight into how supply chain shifts, regional developments, and cross-sector partnerships shape value delivery and market success.

Conclusion

Theranostics creates significant avenues for healthcare decision-makers focused on advancing patient-centric technologies and scalable integrated care. Organizations leveraging these insights will support continued market momentum and improved operational resilience.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Theranostics Market, by Product Type
8.1. Diagnostic Agents
8.2. Therapeutic Agents
9. Theranostics Market, by Technology
9.1. Biomarker-Based Theranostics
9.2. Companion Diagnostics (CDx)
9.3. Gene Therapy-Based Theranostics
9.4. Molecular Imaging
9.5. Nanotechnology-Based Theranostics
9.6. Radiopharmaceutical-Based Theranostics
9.7. Targeted Drug Delivery
10. Theranostics Market, by Application Area
10.1. Autoimmune Disorders
10.2. Cardiovascular Diseases
10.3. Infectious Diseases
10.4. Inflammatory Diseases
10.5. Metabolic Disorders
10.6. Neurological Disorders
10.7. Oncology
10.7.1. Breast Cancer
10.7.2. Lung Cancer
10.7.3. Neuroendocrine Tumors
10.7.4. Prostate Cancer
10.7.5. Thyroid Cancer
11. Theranostics Market, by End-User
11.1. Diagnostic Imaging Centers
11.2. Hospitals & Cancer Care Centers
11.3. Research & Academic Institutes
11.4. Specialty Clinics
12. Theranostics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Theranostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Theranostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Theranostics Market
16. China Theranostics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Actinium Pharmaceuticals, Inc.
17.6. Ariceum Therapeutics GmbH
17.7. Astellas Pharma Inc.
17.8. BAMF Health
17.9. Bayer AG
17.10. bioMérieux SA
17.11. Biosynth Ltd.
17.12. Cardinal Health, Inc.
17.13. Cerebral Therapeutics, Inc.
17.14. Clarity Pharmaceuticals
17.15. Curasight A/S
17.16. Curium Inc.
17.17. Evergreen Theragnostics, Inc.
17.18. GE HealthCare Technologies, Inc.
17.19. Hermes Medical Solutions AB
17.20. Icon Group
17.21. Indi Molecular, Inc.
17.22. Integrated Clinical Oncology Network Pty Ltd.
17.23. Radiopharm Theranostics Limited
17.24. Ratio Therapeutics
17.25. Siemens Healthineers AG
17.26. SOFIE Co.
17.27. Telix Pharmaceuticals Limited
List of Figures
FIGURE 1. GLOBAL THERANOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL THERANOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL THERANOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL THERANOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES THERANOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA THERANOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL THERANOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL THERANOSTICS MARKET SIZE, BY THERAPEUTIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL THERANOSTICS MARKET SIZE, BY BIOMARKER-BASED THERANOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL THERANOSTICS MARKET SIZE, BY BIOMARKER-BASED THERANOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL THERANOSTICS MARKET SIZE, BY BIOMARKER-BASED THERANOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL THERANOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS (CDX), BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL THERANOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS (CDX), BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL THERANOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS (CDX), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THERANOSTICS MARKET SIZE, BY GENE THERAPY-BASED THERANOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THERANOSTICS MARKET SIZE, BY GENE THERAPY-BASED THERANOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THERANOSTICS MARKET SIZE, BY GENE THERAPY-BASED THERANOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL THERANOSTICS MARKET SIZE, BY NANOTECHNOLOGY-BASED THERANOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL THERANOSTICS MARKET SIZE, BY NANOTECHNOLOGY-BASED THERANOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL THERANOSTICS MARKET SIZE, BY NANOTECHNOLOGY-BASED THERANOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICAL-BASED THERANOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICAL-BASED THERANOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICAL-BASED THERANOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL THERANOSTICS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL THERANOSTICS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL THERANOSTICS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL THERANOSTICS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL THERANOSTICS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL THERANOSTICS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THERANOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THERANOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THERANOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THERANOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THERANOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL THERANOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL THERANOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL THERANOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL THERANOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL THERANOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL THERANOSTICS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL THERANOSTICS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL THERANOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL THERANOSTICS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL THERANOSTICS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THERANOSTICS MARKET SIZE, BY THYROID CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THERANOSTICS MARKET SIZE, BY THYROID CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THERANOSTICS MARKET SIZE, BY THYROID CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS & CANCER CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS & CANCER CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS & CANCER CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL THERANOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL THERANOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL THERANOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS THERANOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. EUROPE THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. EUROPE THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 111. EUROPE THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 119. AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. AFRICA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 123. AFRICA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 124. AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL THERANOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASEAN THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 135. ASEAN THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 136. ASEAN THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 137. ASEAN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 138. GCC THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GCC THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. GCC THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. GCC THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 142. GCC THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 143. GCC THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 150. BRICS THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. BRICS THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. BRICS THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. BRICS THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 154. BRICS THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 155. BRICS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 156. G7 THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. G7 THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. G7 THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. G7 THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 160. G7 THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 161. G7 THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 162. NATO THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. NATO THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. NATO THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. NATO THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 166. NATO THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 167. NATO THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES THERANOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 175. CHINA THERANOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. CHINA THERANOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 179. CHINA THERANOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 180. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Theranostics market report include:
  • Actinium Pharmaceuticals, Inc.
  • Ariceum Therapeutics GmbH
  • Astellas Pharma Inc.
  • BAMF Health
  • Bayer AG
  • bioMérieux SA
  • Biosynth Ltd.
  • Cardinal Health, Inc.
  • Cerebral Therapeutics, Inc.
  • Clarity Pharmaceuticals
  • Curasight A/S
  • Curium Inc.
  • Evergreen Theragnostics, Inc.
  • GE HealthCare Technologies, Inc.
  • Hermes Medical Solutions AB
  • Icon Group
  • Indi Molecular, Inc.
  • Integrated Clinical Oncology Network Pty Ltd.
  • Radiopharm Theranostics Limited
  • Ratio Therapeutics
  • Siemens Healthineers AG
  • SOFIE Co.
  • Telix Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.77 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.4 Billion
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Theranostics Market Report 2025 - Product Image

Theranostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Theranostics - Global Strategic Business Report - Product Image

Theranostics - Global Strategic Business Report

  • Report
  • 472 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report 2025 - Product Image

Radiopharmaceutical Theranostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2025 Global Forecast for Pharmacogenomics Technology/Theranostics/Companion Diagnostics (Cdx) Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Pharmacogenomics Technology/Theranostics/Companion Diagnostics (Cdx) Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
2025 Global Forecast for Theranostics Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Theranostics Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Theranostics Market

Theranostics is a field of medicine that combines diagnostics and therapeutics to provide personalized treatments for patients. It is closely related to genomics, which is the study of an individual's genetic makeup. Theranostics uses genomic information to identify the best treatment for a patient, based on their unique genetic profile. This approach is becoming increasingly popular as it allows for more precise and effective treatments. Theranostics is used in a variety of medical fields, including oncology, neurology, and cardiology. It is also being used to develop new treatments for rare diseases. By combining genomic data with other medical information, such as imaging and laboratory tests, doctors can better understand a patient's condition and develop more effective treatments. Some companies in the Theranostics market include Illumina, Thermo Fisher Scientific, and Qiagen. These companies provide products and services related to genomics, such as DNA sequencing, gene expression analysis, and bioinformatics. They also offer products and services related to theranostics, such as biomarker discovery and drug development. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.